Industry: Pharmaceuticals, Biotechnology
Ranking:
Russell 3000
Aastrom Biosciences, Inc. develops autologous cell products for the repair or regeneration of multiple human tissues, based on its proprietary Tissue Repair Cell (TRC) technology. Aastrom’s TRC-based products are a unique cell mixture containing stem and progenitor cell populations, produced from a small amount of bone marrow taken from the patient. TRC-based products have been used in over 240 patients, and are currently in clinical trials for bone regeneration (osteonecrosis of the femoral head, long bone fractures and spine fusion) and vascular regeneration (critical limb ischemia) applications. Aastrom has reported positive interim clinical trial results for TRCs suggesting both the clinical safety and the ability of TRCs to promote healing in bone regeneration ( www.aastrom.com )
Aastrom Biosciences , Inc.
24 Frankl Lloyd Wright Dr Po Box 376
Ann Arbor, Michigan 48106
USA
Tel: (734) 930-5555
Fax: (734) 665-0485